Dermal fillers made of hyaluronic acid are the least intrusive cosmetic procedures. Globally, dermatology issues are prevalent. Understanding the goods to cure skin-related issues and reduce wrinkles has become a key concern. Several initiatives have been taken to raise knowledge of the proper administration of injectable hyaluronic acid. With more awareness, consumers can choose the proper therapy for wrinkles and acne and choose the appropriate product (Botox injection, dermal fillers) based on the right cause. As a result, the sales will increase, the product line will grow, and the product portfolio will grow. This element is anticipated to fuel market expansion.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-hyaluronic-acid-market
Data Bridge Market Research analyses that the Hyaluronic Acid Market is expected to grow at a CAGR of 8.3% in the forecast period of 2023 to 2030 and is expected to reach from USD 16,313.95 million by 2030 from USD 740.169 million in 2022.
Key Findings of the Study
The use of Invasive Hyaluronic Acid Based Dermal Fillers are expected to drive the market
Dermal fillers made of hyaluronic acid are less invasive cosmetic procedures that are rapidly spreading throughout the world. These are common cosmetic operations for enhancing one's appearance and restoring facial volume. They are applied to fine lines and wrinkles and have a wide range of uses. These are also used to enlarge the lips, cheeks, and chin as well as to treat acne, wrinkles, and scars. The demand for non-invasive surgical protocols has increased due to the increase in the elderly population. The use of dermal fillers made of hyaluronic acid will lessen the need for traditional surgery. There is a low cost of therapy, which will stimulate market expansion.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Grade (Cosmetic Grade and Pharmaceutical Grade), Type (Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronic Acid, and Sodium Hyaluronate), Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Ophthalmology, and Others), End User (Medical Spas and Beauty Centers, Dermatology Clinics, and Cosmetic Surgery Centers), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Allergan (Ireland), Anika Therapeutics, Inc. (U.S), Bio Plus Co., Ltd. (South Korea), Bioxis Pharmaceuticals (France), Bohus Biotech AB (Sweden), Candela Medical (U.S.), Galderma Laboratories L.P. (U.S.), Genzyme Corp. (U.S.), NUVISAN GmbH (Germany), Laboratoires Vivacy (France), LG Chem (South Korea), Medicis Aesthetics Holdings, Inc. (U.S.), Merz Pharmaceuticals (Germany), Sculpt Luxury Dermal Fillers Ltd. (U.S.), Sinclair Pharma (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global hyaluronic acid market is categorized into five notable segments based on grade, type, application, end user, and distribution channel.
- Based on grade, the market is segmented into cosmetic grade and pharmaceutical grade. The cosmetic grade segment is expected to dominate the market with a share of 68.09% due to rising aesthetic consciousness that improves physical characteristics.
- Based on type, the market is segmented into hydrolyzed hyaluronic acid, sodium acetylated hyaluronic acid, and sodium hyaluronate. The sodium hyaluronate segment is expected to dominate the market with a market share of 85.10% due to its number of benefits, it helps to restore the skin's moisture, promoting a more revitalized and youthful complexion. Sodium hyaluronate is gentle enough for use on most skin types, including acne-prone types. It smoothens the appearance of wrinkles and improves the skin and in medication, it can be injected directly into the knee to relieve pain caused by osteoarthritis.
- Based on application, the market is segmented into aesthetics, osteoarthritis, pharmaceutical API, cosmetics, ophthalmology, and others.
The aesthetics segment is expected to dominate the hyaluronic acid market
The aesthetics segment is expected to dominate the market with a share of 37.55% due to the increasing awareness of anti-aging goods and increased demand for hyaluronic-based products such as moisturizers, dermal fillers, shampoo, and others, which will further boost the segment growth and market demand.
- Based on end user, the market is segmented into medical spas and beauty centers, dermatology clinics, and cosmetic surgery centers.
The dermatology clinics segment is expected to dominate the hyaluronic acid market
The dermatology clinics segment is expected to dominate the market with a share of 46.07% due to rising healthcare expenditure and awareness of various over-the-counter drugs among the population.
- Based on distribution channel, the market is segmented into direct tender and retail sales. The retail sales segment is expected to dominate the market with a share of 57.64% as they track consumer demand for finished goods by measuring the purchases of durable & non-durable goods over a defined period of time.
Major Players
Data Bridge Market Research recognizes the following companies as the major hyaluronic acid market players in hyaluronic acid market are Allergan (Ireland), Anika Therapeutics, Inc. (U.S), Bio Plus Co., Ltd. (South Korea), Bioxis Pharmaceuticals (France), Bohus Biotech AB (Sweden), Candela Medical (U.S.), Galderma Laboratories L.P. (U.S.), Genzyme Corp. (U.S.), NUVISAN GmbH (Germany), Laboratoires Vivacy (France), LG Chem (South Korea), Medicis Aesthetics Holdings, Inc. (U.S.), Merz Pharmaceuticals (Germany), Sculpt Luxury Dermal Fillers Ltd. (U.S.), Sinclair Pharma (U.S.)
Market Development
- In 2022, JUVÉDERM VOLBELLA XC was FDA-approved, according to a statement from Allergan, a division of AbbVie Inc., for the treatment of infraorbital hollows in individuals over the age of 21. This aided the business in growing its aesthetics product line in the market.
- In 2021, Contipro, a well-known hyaluronic acid producer with headquarters in the Czech Republic, announced the release of HyRetin, a new anti-aging and anti-acne therapy solution that enhances skin visibility.
- In 2019, TACTOSET, a hyaluronic acid-based surgically administered regeneration therapy, was introduced by Anika Therapeutics in the U.S. to address bone abnormalities brought on by trauma or degeneration.
Regional Analysis
Geographically, the countries covered in the hyaluronic acid market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in hyaluronic acid market in the forecast period 2023 - 2030
North America is dominating due to the rise in product approvals, there is a sizable base of the elderly population which are more prone to diseases such as osteoarthritis, vesicoureteral reflux, and cataracts.
Asia-Pacific is estimated to be the fastest growing region in hyaluronic acid market in the forecast period 2023 - 2030
Asia-Pacific is expected to dominate the global hyaluronic acid market because there is a growing interest in using anti-aging products, the ageing populations in China and Japan provide a large customer base for anti-aging goods and services. The demand is fueled by growing knowledge of the uses for hyaluronan and its effectiveness.
COVID-19 Impact Analysis
The demand for hyaluronic acid decreased despite the fact that it has important uses in elective treatments due to COVID-19 restrictions, particularly in the early phases of the pandemic. Additionally, patients decided against or delayed surgeries even in the later stages of the pandemic to reduce their risk of infection, which had a negative effect on the market and reduced market revenue. The utilization of hyaluronic acid-based supplements significantly decreased during the pandemic. According to Anika Therapeutics, the use of hyaluronic acid supplements for osteoarthritis has decreased by 24% which is one of the main providers of these products. The post-pandemic is anticipated to be driven by the loosening of pandemic restrictions around the world and the increasing preference for elective injection-based procedures over operations. As pandemic restrictions loosen around the world, a preference for injection-based elective procedures over surgeries has been observed, which is expected to boost the hyaluronic acid market.
For more detailed information about the hyaluronic acid market report, click here – https://www.databridgemarketresearch.com/reports/global-hyaluronic-acid-market
